Sign up USA
Proactive Investors - Run By Investors For Investors

Imagination Technologies, Red Hat, MabVax Therapeutics Holdings and more - AFTER HOURS

Proactive Investors takes a look at what happened after hours in New York and what's moving the needle in pre-market deals
Imagination Technologies, Red Hat, MabVax Therapeutics Holdings and more - AFTER HOURS
Chip marker Imagination Technologies was in focus

There's some Fed talk today coming from the central bank's presidents in New York, Chicago and Minneapolis today after last week's hawkish tone but in company news, biotech MabVax Therapeutics Holdings Inc (NASDAQ:MBVX) may grab some  limelight.

Shares plunged almost 10% to US$0.67 on Friday after it reported a$1.25 million offering to sell around 2mln of its shares at 62 cents each.

Elsewhere, Apple's (NASDAQ:AAPL) chip supplier Imagination Technologies Group plc (LON:IMG) is seeing shares blast nearly 30% higher in London today

It comes as the group late last  week unveiled a deal to be sold to a China-backed private equity firm Canyon Bridge.

Analysts today indicated confidence that the deal would be approved.

In other news, D.R. Horton Inc (NYSE: DHI) saw shares slump over 3.74% after hours, after the house builder slashed, due to the recent hurricanes, its expectations for its backlog conversion rate for the  fourth quarter.

The company now expects a conversion rate of about 85%, down from previous guidance of 88% to 90%.

Elsewhere, multi-national software firm Red Hat Inc (NYSE:RHT) saw shares nudge 0.66% higher after - hours as Wall Street expects it to have earned $0.67 per share on revenue of $699.54mln.

The group is reporting earnings after the markets close. Red Hat shares slipped 0.51% to close at $106.30 last week.

 

View full IMG profile View Profile

Imagination Technologies Group Timeline

Article
September 17 2014

Related Articles

1505844466_RESAAS-image-for-profile-article.jpg
September 19 2017
Build the audience then pull the monetization levers -- a tried and true tech sector model
Scientists looking into a micrscope
September 26 2017
"Following a period of planned strategic progress, Instem is now undoubtedly better positioned for profitable growth than ever before”
Office productivity
September 11 2017
It would have been somewhat embarrassing had an office productivity software firm not got its flagship product delivered on time, but fortunately BOS did

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You understand that the Company receives either monetary or securities compensation for our services. We stand to benefit from any volume this write-up may generate.

You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Copyright © Proactiveinvestors.com, 2017. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use